This content is from: Premium Bronte Capital’s John Hempton Still Loves Herbalife As the stock continued to fall, the firm doubled down. By Michelle Celarier May 14, 2020
This content is from: Premium The Obscure Hedge Fund Betting Huge on Herbalife Deccan Value sunk 40 percent of its portfolio in the controversial diet-shake seller, becoming the third-biggest investor. By Michelle Celarier February 21, 2020
This content is from: Premium Herbalife’s Hedge Fund Bulls Flee Problems with its business in China are deepening, making the stock one of the year’s worst performers. By Michelle Celarier August 16, 2019
This content is from: Premium Despite Strong Earnings, Herbalife Shares Sink The stock is falling this year as investigations linger. By Michelle Celarier April 08, 2019
This content is from: Portfolio Ackman Calls it Quits on Herbalife Bet Ackman says he has exited Pershing Square's long-running bet against Herbalife, the company he called a pyramid scheme. By Amy Whyte February 28, 2018
This content is from: Premium Carl Icahn Rocks Herbalife Shareholders Over Stock Sale The investor tried to reassure Herbalife shareholders after unloading one-quarter of his position in a Dutch tender offer. By Stephen Taub May 29, 2018
Sponsored Stability Amidst Risk and Volatility Multi-asset risk mitigation strategies are in demand in trying times. Here’s why. Sponsored by Invesco July 28, 2020
Sponsored You Still Need to Strengthen Portfolio Resilience How COVID-19 will play out remains uncertain. Multi-asset strategies have the flexibility and potential to address risks as they evolve. Sponsored by Invesco July 28, 2020
